Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism

Journal of Family Planning and Reproductive Health Care

Volumn 38, Issue 2, 2012, Pages 137-138

  Leppée, Marcel ^a   Culig, Josip ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ETHINYLESTRADIOL PLUS NORGESTREL; LOGEST; UNCLASSIFIED DRUG; ORAL CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE;

CARDIOVASCULAR RISK; CEREBRAL SINUS THROMBOSIS; CROATIA; DEEP VEIN THROMBOSIS; DRUG UTILIZATION; FEMALE; HEADACHE; HUMAN; LETTER; LUNG EMBOLISM; MUSCLE SPASM; NAUSEA; SUPERFICIAL THROMBOPHLEBITIS; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED; INFORMATION PROCESSING; PROCEDURES; STATISTICAL ANALYSIS;

CONTRACEPTIVES, ORAL, COMBINED; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; PROGESTERONE CONGENERS; VENOUS THROMBOEMBOLISM;

EID: 84860771685     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1136/jfprhc-2012-100297     Document Type: Letter

References (2)

1. Dinger J, Shapiro S. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets. J Fam Plann Reprod Health Care 2012;38:2-6.
2. Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 2001;323:131-134. (Pubitemid 32678382)